The human leukemia cell line HL-60 can be induced to differentiate in vitro, permitting a recombinant DNA analysis of the complex series of differentiation steps leading from promyelocytes to either macrophages or granulocytes. We have isolated many genes which are strongly regulated. Characterization during the past year included discovery of a new human tubulin gene and the first human ferritin L subunit clones among the regulated genes as well as a gamma-actin with an amino acid substitution in a sequence normally highly conserved. Mutant beta-actin genes have been implicated as important in affecting oncogenic or metastatic potential. This is the first indication that gamma-actin alterations may have similar effects. Our main emphasis remains the development of a system for using site-directed mutagenesis to study commitment and terminal differentiation in human cells. We have now succeeded in obtaining efficient transfection of HL-60 cells with the pSV2neo vector. By cotransformation, tagged versions of genomic clones for genes which show strong regulation during HL-60 differentiation have also been inserted. Several tagged genes are expressed at high levels and show appropriate regulation. This suggests that we have succeeded in developing the first system permitting the use of site-directed mutagenesis to study the irreversible gene regulation changes occurring during the terminal differentiation of human cells. At the same time we have obtained evidence suggesting that gene regulation during myeloid terminal differentiation involves a complex series of gene switching events. Instead of a single coordinate turn-on, as has been seen in muscle or reticulocyte differentiation, we see a complex series of changes in the levels of different mRNAs. Translational regulation is also important, and in the case of the alpha-tubulin mRNA we have identified an unusual sequence in the 5' untranslated region which may explain a very strong translational regulation. (M)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032186-12
Application #
3170166
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1982-05-01
Project End
1987-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
12
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Davis, R C; Thomason, A R; Fuller, M L et al. (1987) mRNA species regulated during the differentiation of HL-60 cells to macrophages and neutrophils. Dev Biol 119:164-74
Chou, C C; Davis, R C; Fuller, M L et al. (1987) Gamma-actin: unusual mRNA 3'-untranslated sequence conservation and amino acid substitutions that may be cancer related. Proc Natl Acad Sci U S A 84:2575-9
Gatti, R A; Shaked, R; Wei, S et al. (1987) Biallelic DNA polymorphism of an alpha-tubulin gene family member on chromosome 12 [TUBA/MspI/2.2;2.0 kb] Nucleic Acids Res 15:8119
Gatti, R A; Shaked, R; Mohandas, T K et al. (1987) Human ferritin genes: chromosomal assignments and polymorphisms. Am J Hum Genet 41:654-67
Chou, C C; Gatti, R A; Fuller, M L et al. (1986) Structure and expression of ferritin genes in a human promyelocytic cell line that differentiates in vitro. Mol Cell Biol 6:566-73